Pharming Group N.V. PHGUF
Set alert
0.96 USD 0.00 0.00%
At close · Oct 30
0.9545 Day range 0.9545
0.929 52-week range 2.15
- YTD
- -42.12%
- 1 year
- -36.33%
- Open
- 0.9545
- Prev close
- 0.955
- Mkt cap
- 675.93M
- Vol
- 1.00K
- Avg vol
- 132
- EPS
- 0.03
- P/E
- 31.83
More statistics
- Low
- 0.9545
- High
- 0.9545
- Earnings
- Aug 1, 2024
2Y chart
Signals (48)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 28, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
| RSI: Oversold | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 30, 2026 | 3 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| RSI: Oversold | May 7, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 10, 2026 | 6 months ago |
| RSI: Overbought | Apr 10, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 17, 2026 | 7 months ago |
| RSI: Oversold | Mar 3, 2026 | 8 months ago |
| SMA: Bearish | Feb 13, 2026 | 8 months ago |
| RSI: Oversold | Feb 13, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 12, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 16, 2026 | 9 months ago |
| RSI: Overbought | Jan 16, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| SMA: Bullish | Nov 6, 2025 | 11 months ago |
| SMA: Bearish | Nov 5, 2025 | 12 months ago |
| RSI: Oversold | Nov 5, 2025 | 12 months ago |
| MACD: Sell Signal | Sep 19, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 22, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 20, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 15, 2025 | 1 year ago |
| RSI: Overbought | Aug 11, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 23, 2025 | 1 year ago |
| RSI: Overbought | Jun 18, 2025 | 1 year ago |
| MACD: Buy Signal | May 19, 2025 | 1 year ago |
| RSI: Overbought | May 19, 2025 | 1 year ago |
| MACD: Sell Signal | May 16, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 29, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 11, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 11, 2025 | 1 year ago |
| RSI: Oversold | Mar 11, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| SMA: Bullish | Feb 27, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 27, 2025 | 1 year ago |
| RSI: Overbought | Feb 27, 2025 | 1 year ago |
| SMA: Bearish | Feb 4, 2025 | 1 year ago |
| RSI: Oversold | Feb 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| RSI: Overbought | Dec 17, 2024 | 1 year ago |
Next earnings
Aug 1, 2024
Expected Aug 1, 2024. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 24, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 1, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.00 | -0.02 | — | — |
| Mar 14, 2024 | Dec 1, 2023 | 0.00 | 0.00 | — | — |
| Oct 26, 2023 | Sep 1, 2023 | 0.00 | 0.01 | — | — |
| Aug 3, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
- Pharming Group: Viable Contrarian Buy If Ruconest Stabilizes
- Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
- FDA approves Pharming's Joenja® as first treatment for children with APDS in the U.S.
- Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
- Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
- Pharming Group announces results of 2026 Annual General Meeting of Shareholders
- Pharming Group N.V. (PHAR) Q1 2026 Earnings Call Transcript
- Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
- Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
- Pharming Group N.V. (PHAR) Q4 2025 Earnings Call Transcript
Your note
Sign in to keep a note on PHGUF — it syncs with the Stock Master app.